Status:
SUSPENDED
Submucosal Tumor Removal by Endoscopic Excision Therapy
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Collaborating Sponsors:
Ovesco Endoscopy AG
Conditions:
Submucosal Tumor of Stomach
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Smaller submucosal tumors (SMT) in the stomach are usually seen as an incidental finding during a gastroscopy, although current diagnostics usually do not clearly indicate what type of tumor it is. In...
Detailed Description
Smaller submucous tumors in the stomach are usually seen as a random finding in gastroscopies and present a diagnostic dilemma to the doctor and patient: type specification is usually unclear whether...
Eligibility Criteria
Inclusion
- Patients with endoscopically diagnosed and endosonographically confirmed submucosal tumors of 0.5 to 2 cm in the stomach without definitive histology / cytology
- Initial diagnosis less than 2 years ago
- No contraindication to endoscopic resection
- Patient's informed consent
Exclusion
- Tumor size \> 2 cm
- Tumors with proven / suspected malignancy for which oncologically no endoscopic resection should be performed, i.e. for which oncological or surgical therapy is planned
- SMT known \> 2 Years
- Patients with severe general illnesses (limited operability) or malignancies
- Clotting disorders
- Pregnancy
Key Trial Info
Start Date :
March 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04913077
Start Date
March 10 2020
End Date
February 1 2025
Last Update
March 19 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Freiburg
Freiburg im Breisgau, Germany, 79106
2
University Hospital Hamburg Eppendorf
Hamburg, Germany, 20246
3
University Hospital Marburg
Marburg, Germany, 35039